A brief overview of the use of rubidium in affective disorders and schizophrenia is presented. Although antidepressant action of rubidium has not been supported by adequate number of controlled studies, its potential contribution to psychiatry warrants further investigations. Endogenous rubidium may be a useful research tool in the future psychopharmacological studies of affective disorders.